|
|
||||||||
1Diabetes and Obesity Research Program, Garvan Institute of Medical Research, Darlinghurst; and 2St. Vincent's Hospital Medical School, University of New South Wales, Sydney, New South Wales, Australia
Submitted 21 April 2006 ; accepted in final form 4 May 2006
Accumulation of intracellular lipid in obesity is associated with metabolic disease in many tissues including liver. Storage of fatty acid as triglyceride (TG) requires the activation of fatty acids to long-chain acyl-CoAs (LC-CoA) by the enzyme acyl-CoA synthetase (ACSL). There are five known isoforms of ACSL (ACSL1, -3, -4, -5, -6), which vary in their tissue specificity and affinity for fatty acid substrates. To investigate the role of ACSL1 in the regulation of lipid metabolism, we used adenoviral-mediated gene transfer to overexpress ACSL1 in the human hepatoma cell-line HepG2 and in liver of rodents. Infection of HepG2 cells with the adenoviral construct AdACSL1 increased ACSL activity >10-fold compared with controls after 24 h. HepG2 cells overexpressing ACSL1 had a 40% higher triglyceride (TG) content (93 ± 3 vs. 67 ± 2 nmol/mg protein in controls, P < 0.05) after 24-h exposure to 1 mM oleate. Furthermore, ACSL1 overexpression produced a 60% increase in cellular LCA-CoA content (160 ± 6 vs. 100 ± 6 nmol/g protein in controls, P < 0.05) and increased [14C]oleate incorporation into TG without significantly altering fatty acid oxidation. In mice, AdACSL1 administration increased ACSL1 mRNA and protein more than fivefold over controls at 4 days postinfection. ACSL1 overexpression caused a twofold increase in TG content in mouse liver (39 ± 4 vs. 20 ± 2 µmol/g wet wt in controls, P < 0.05), and overexpression in rat liver increased [1-14C]palmitate clearance into liver TG. These in vitro and in vivo results suggest a pivotal role for ACSL1 in regulating TG synthesis in liver.
acyl-coenzyme A synthetase; hepatic triglyceride synthesis; adenovirus; fatty acid metabolism
This article has been cited by other articles:
![]() |
V. Saraswathi and A. H. Hasty Inhibition of Long-Chain Acyl Coenzyme A Synthetases During Fatty Acid Loading Induces Lipotoxicity in Macrophages Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1937 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. O. Li, J. M. Ellis, H. A. Paich, S. Wang, N. Gong, G. Altshuller, R. J. Thresher, T. R. Koves, S. M. Watkins, D. M. Muoio, et al. Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and {beta}-Oxidation and Alters Phospholipid Fatty Acid Composition J. Biol. Chem., October 9, 2009; 284(41): 27816 - 27826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bionaz and J. J. Loor ACSL1, AGPAT6, FABP3, LPIN1, and SLC27A6 Are the Most Abundant Isoforms in Bovine Mammary Tissue and Their Expression Is Affected by Stage of Lactation J. Nutr., June 1, 2008; 138(6): 1019 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, P. Abidi, A. Kim, W. Chen, T.-T. Huang, F. B. Kraemer, and J. Liu Transcriptional Activation of Hepatic ACSL3 and ACSL5 by Oncostatin M Reduces Hypertriglyceridemia Through Enhanced {beta}-Oxidation Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2198 - 2205. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |